Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Virology|October 13, 2012
Virus-host interactomes--antiviral drug discoveryYue Ma-Lauer, Jian Lei, Rolf Hilgenfeld, et al.
Antiviral Research|October 22, 2019
Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replicationYue Ma-Lauer, Yu Zheng, Miroslav Malešević, et al.
Virology|August 2, 2016
Tubulins interact with porcine and human S proteins of the genus Alphacoronavirus and support successful assembly and release of infectious viral particlesAnna-Theresa Rüdiger, Peter Mayrhofer, Yue Ma-Lauer, et al.
International Journal of Biological Macromolecules|September 29, 2024
The CoV-Y domain of SARS-CoV-2 Nsp3 interacts with BRAP to stimulate NF-κB signaling and induce host inflammatory responsesKai Wang, Xincheng Ni, Xinyue Deng, et al.
Molecular Pharmacology|October 12, 2023
Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2-Induced InflammationFan Yang, Chenglong Liu, Pengyuan Li, et al.
Frontiers in Cellular and Infection Microbiology|October 10, 2022
Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection modelsEmilia J Berthold, Yue Ma-Lauer, Ashesh Chakraborty, et al.
The EMBO Journal|April 20, 2021
The SARS-unique domain (SUD) of SARS-CoV and SARS-CoV-2 interacts with human Paip1 to enhance viral RNA translationJian Lei, Yue Ma-Lauer, Yinze Han, et al.
Virus Research|February 26, 2014
Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including AlisporivirJavier Carbajo-Lozoya, Yue Ma-Lauer, Miroslav Malešević, et al.
Pathogens (Basel, Switzerland)|September 27, 2025
LMP7 as a Target for Coronavirus Therapy: Inhibition by Ixazomib and Interaction with SARS-CoV-2 Proteins Nsp13 and Nsp16Yi Ru, Yue Ma-Lauer, Chengyu Xiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2016
p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1Yue Ma-Lauer, Javier Carbajo-Lozoya, Marco Y Hein, et al.
Pageof 2